EX-99.1 2 ea030472001ex99-1.htm AUDITED BALANCE SHEET AS OF AUGUST 31, 2026 Exhibit 99.1 Inflection Point Acquisition Corp. VIII INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of Inflection Point Acquisition Corp. VIII: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of August 31, 2026 F-3 Notes to Financial Statement F-4 F-1 Report of Independent Registered Public Accounting Firm To the Board of Directors and Shareholders of Inflection Point Acquisition Corp. VIII: Opinion on the Financial Statement We have audited the accompanying balance sheet of Inflection Point Acquisition Corp. VIII (the “Company”) as of August 31, 2026, and the related notes (collectively referred to as the “financial statement”). In our opinion, the financial statement presents fairly, in all material respects, the financial position of the Company as of August 31, 2026, in conformity with accounting principles generally accepted in the United States of Amer…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
Inflection Point Acquisition Corp. VIII
IPHXNASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events. As previously reported, on August 31, 2026, Inflection Point Acquisition Corp. VIII (the “Company”) consummated its initial public offering (“IPO”) of 28,750,000 units (the “Units”), including the issuance of 3,750,000 Units as a result of the underwriters’ exercise of their over-allotment option in full.…
Company context
Inflection Point Acquisition Corp. VIII’s acquisition and value creation strategy is to identify, partner with and help grow North American and European businesses in disruptive growth sectors, which complements the expertise of its management team.
Current securities
Recent company filings
- Other EventsSep 30, 2026
- 10-Q filingSep 28, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other EventsSep 2, 2026
- 424B4 filingAug 31, 2026
- EFFECT filingAug 27, 2026
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
As previously reported, on
August 31, 2026, Inflection Point Acquisition Corp. VIII (the “Company”) consummated its initial public offering (“IPO”)
of 28,750,000 units (the “Units”), including the issuance of 3,750,000 Units as a result of the underwriters’
exercise of their over-allotment option in full. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per
share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant. The Units were sold at a price of $10.00
per Unit, generating gross proceeds to the Company of $287,500,000.
Also as previously reported,
on August 31, 2026, simultaneously with the consummation of the IPO, the Company completed the private sale (the “Private Placement”)
of an aggregate of 8,000,000 private placement warrants (the “Private Placement Warrants”) to Inflection Point Holdings
VIII LLC (the “Sponsor”) and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC,
as representative of the underwriters (the “Representative”) at a purchase price of $1.00 per Private Placement Warrant,
generating gross proceeds to the Company of $8,000,000. Of the 8,000,000 Private Placement Warrants, the Sponsor purchased 5,000,000 Private
Placement Warrants and the Representative purchased 3,000,000 Private Placement Warrants.
A total of $287,500,000 of
the proceeds from the IPO and Private Placement, which amount includes up to $13,687,500 of the underwriters’ deferred discount,
was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
An audited balance sheet as
of August 31, 2026 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company
and is included as Exhibit 99.1 to this Current Report on Form 8-K.